CrossrefInfokarte
Patterns of progression and efficacy of immune checkpoint inhibitors in unresectable, recurrent, or metastatic cholangiocarcinoma: A real-world study
Digestive and Liver Disease · 2026-10 · 58 (10) · 1339-1348
DOI: 10.1016/j.dld.2026.07.013 ↗Abstract
Kein Abstract verfügbar.
EUVIMED